We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$15.8B
AUM Growth
+$600M
(+4%)
Cap. Flow
+$62.2M
Cap. Flow % of AUM
Cap. Flow %
0.39%
Top 10 Holdings %
Top 10 Hldgs %
39.24%
Holding
1,522
New
71
Increased
243
Reduced
326
Closed
55
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$93.8M |
| 2 |
Zimmer Biomet
ZBH
|
+$62.6M |
| 3 |
Gilead Sciences
GILD
|
+$35.1M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$25.2M |
| 5 |
Honeywell
HON
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$90.2M |
| 2 |
SunTrust Banks, Inc.
STI
|
+$33.6M |
| 3 |
AstraZeneca
AZN
|
+$23.3M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$20.1M |
| 5 |
Innoviva
INVA
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.38% |
| 2 | Healthcare | 11.82% |
| 3 | Industrials | 8.89% |
| 4 | Energy | 8.06% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.16T
| $3.23B | 20.47% |
17,007
-30
| -0.2% | -$5.69M |
2013 Q2
4 quarters
|
|
2
Brookfield
BN
$84.8B
| $547M | 3.47% |
53,119,379
-1,298,427
| -2% | -$13M |
2013 Q2
4 quarters
|
|
3
CVS Health
CVS
$120B
| $338M | 2.14% |
4,484,312
-88,651
| -2% | -$6.7M |
2013 Q2
4 quarters
|
|
4
Wells Fargo
WFC
$247B
| $325M | 2.06% |
6,180,500
-37,934
| -0.6% | -$1.91M |
2013 Q2
4 quarters
|
|
5
Range Resources
RRC
$10.6B
| $314M | 1.99% |
3,606,261
-75,791
| -2% | -$6.78M |
2013 Q2
4 quarters
|
|
6
Berkshire Hathaway Class B
BRK.B
$1.16T
| $313M | 1.99% |
2,475,074
+11,002
| +0.4% | +$1.39M |
2013 Q2
4 quarters
|
|
7
AB InBev
BUD
$166B
| $308M | 1.95% |
2,677,891
-15,534
| -0.6% | -$1.71M |
2013 Q2
4 quarters
|
|
8
Microsoft
MSFT
$3.89T
| $286M | 1.81% |
6,865,858
-15,122
| -0.2% | -$612K |
2013 Q2
4 quarters
|
|
9
Johnson & Johnson
JNJ
$635B
| $276M | 1.75% |
2,633,436
-9,198
| -0.3% | -$930K |
2013 Q2
4 quarters
|
|
10
ConocoPhillips
COP
$181B
| $256M | 1.62% |
2,981,691
+19,718
| +0.7% | +$1.54M |
2013 Q2
4 quarters
|
|
11
American International
AIG
$42.5B
| $240M | 1.52% |
4,391,017
+200,268
| +5% | +$10.6M |
2013 Q2
4 quarters
|
|
12
RTX Corp
RTX
$258B
| $230M | 1.46% |
3,166,515
-14,851
| -0.5% | -$1.09M |
2013 Q2
4 quarters
|
|
|
DISCK
13
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $220M | 1.39% |
6,057,264
+176,450
| +3% | +$6.47M |
2013 Q2
4 quarters
|
|
|
14
Honeywell
HON
$70.1B
| $188M | 1.19% |
2,248,269
+202,973
| +10% | +$17M |
2013 Q2
4 quarters
|
|
|
15
Oracle
ORCL
$382B
| $182M | 1.15% |
4,481,061
+2,278,881
| +103% | +$93.8M |
2013 Q2
4 quarters
|
|
16
Apple
AAPL
$5.07T
| $171M | 1.08% |
7,347,480
+38,164
| +0.5% | +$812K |
2013 Q2
4 quarters
|
|
17
IBM
IBM
$240B
| $169M | 1.07% |
973,515
-31,343
| -3% | -$5.64M |
2013 Q2
4 quarters
|
|
18
Jefferies Financial Group
JEF
$10.3B
| $156M | 0.99% |
6,641,534
-255,360
| -4% | -$5.93M |
2013 Q2
4 quarters
|
|
|
UPL
19
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $153M | 0.97% |
5,163,217
-193,402
| -4% | -$5.5M |
2013 Q2
4 quarters
|
|
20
Ameren
AEE
$29.9B
| $151M | 0.96% |
3,700,908
-25,250
| -0.7% | -$1.01M |
2013 Q2
4 quarters
|
|
21
Comcast
CMCSA
$80.5B
| $149M | 0.94% |
5,553,094
+91,836
| +2% | +$2.36M |
2013 Q2
4 quarters
|
|
|
VIAB
22
DELISTED
Viacom Inc. Class B
VIAB
| $142M | 0.9% |
1,642,180
+116,849
| +8% | +$9.9M |
2013 Q2
4 quarters
|
|
23
American Express
AXP
$212B
| $142M | 0.9% |
1,495,588
-12,015
| -0.8% | -$1.08M |
2013 Q2
4 quarters
|
|
24
Procter & Gamble
PG
$374B
| $141M | 0.9% |
1,799,710
-10,524
| -0.6% | -$849K |
2013 Q2
4 quarters
|
|
25
Old Republic International
ORI
$9.39B
| $140M | 0.89% |
8,460,748
-232,300
| -3% | -$3.88M |
2013 Q2
4 quarters
|
|
Similar funds
First Manhattan's Q2 2014 Portfolio in Review
As of Q2 2014, First Manhattan held 1,522 positions worth $15.8B, up 4% from $15.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
First Manhattan's Q2 2014 filing shows 71 new, 243 increased, 326 reduced and 55 closed positions. Its largest new stake was Navient: 627,603 shares worth $11.1M. The largest sale was Gen Digital, an estimated $90.2M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q2 2014 buy was Navient: 627,603 shares worth $11.1M.
- First Manhattan added most to Oracle in Q2 2014, an estimated $93.8M increase.
- First Manhattan's biggest Q2 2014 reduction was Gen Digital, cutting an estimated $90.2M.
- First Manhattan fully exited Cardiovascular Systems, Inc. in Q2 2014, selling an estimated $8.26M.
- First Manhattan's ten largest holdings make up 39% of its $15.8B portfolio in Q2 2014.
- First Manhattan opened 71 new positions and closed 55 in Q2 2014.
- First Manhattan's portfolio value rose 4% quarter-over-quarter to $15.8B.
Based on First Manhattan's 13F filing for Q2 2014, filed 14 Aug 2014.